Potentiation of hypoglycemic effect of sulfonylureas by halofenate.

Abstract	We investigated the possibility of a drug interaction between the antilipemic agent halofenate and sulfonylureas. Twelve young, healthy men were given 1 g of tolbutamide by mouth before and after 12 days of double-blind treatment with 1 g per day of halofenate, or placebo. There was a significant increase in serum tolbutamide at eight, 10 and 12 hours (P less than 0.01) and a significant (P less than 0.01) decrease in serum glucose at one, four and six hours after halofenate treatment, but not after placebo. In a long-term, double-blind study of halofenate or clofibrate treatment of patients with Type IV hyperlipoproteinemia, diabetic patients receiving a sulfonylurea and halofenate either required a reduction in the dose of the sulfonylurea or demonstrated significantly improved control of hyperglycemia (P less than 0.05) or both. No appreciable decrease in serum glucose levels was noted in diabetic patients receiving sulfonylurea and clofibrate. This interaction between halofenate and sulfonylureas is clinically important, especially in view of the association of hyperlipemia and diabetes.
Authors	A K Jain, J R Ryan, F G McMahon
Journal	The New England journal of medicine (N Engl J Med) Vol. 293 Issue 25 Pg. 1283-6 (Dec 18 1975) ISSN: 0028-4793 [Print] United States
PMID	171574 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References	Glycolates Hypoglycemic Agents Lipoproteins, VLDL Sulfonylurea Compounds Triglycerides Tolbutamide Phenformin Clofibrate Halofenate
Topics	Adult Clinical Trials as Topic Clofibrate (administration & dosage, therapeutic use) Diabetes Complications Diabetes Mellitus (drug therapy) Drug Synergism Female Glycolates (pharmacology) Halofenate (administration & dosage, pharmacology, therapeutic use) Humans Hyperlipidemias (drug therapy) Hypoglycemic Agents (pharmacology) Lipoproteins, VLDL (blood) Male Middle Aged Phenformin (administration & dosage, therapeutic use) Sulfonylurea Compounds (administration & dosage, pharmacology, therapeutic use) Tolbutamide (pharmacology, therapeutic use) Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!